JOURNAL OF CHEMICAL RESEARCH 2011 673
Table 1 Synthesis of compounds 4a–e
δ: 4.04, 4.13 (d, 2H, CH2), 6.83 (s, 1H, CH), 7.05–7.55 (m, 8H, Hring),
12.47 (s, 1H, NHbenzimidazole); IR(KBr)υ: 3063, 2918, 1684, 1536, 1470,
1111 cm−1; Anal. Calcd for C16H12ClN3OS: C, 58.27; H, 3.67; N,
12.74. Found: C, 58.18; H, 3.46; N, 12.51%.
Entry R
Mode of Time
activation
Power/
Yield
temperature /%
3-(1H-benzo[d]imidazol-2-yl)-2-(4-fluorophenyl)thiazolidin-4-one
(4b): Yield, 79%; m.p. 191–192 °C; 1H NMR (DMSO-d6, 500MHz)
δ: 3.96, 4.23 (d, 2H, CH2), 6.77 (s, 1H, CH), 7.07–7.52 (m, 8H, Hring),
12.41 (s, 1H, NHbenzimidazole); IR(KBr)υ: 3063, 2914, 1705, 1535, 1485,
1222 cm−1; Anal. Calcd for C16H12FN3OS: C, 61.33; H, 3.86; N, 13.41.
Found: C, 62.08; H, 3.46; N, 13.01%.
3-(1H-benzo[d]imidazol-2-yl)-2-(4-nitrophenyl)thiazolidin-4-one
(4c):Yield, 85%; m.p. 225–226 °C; 1H NMR (DMSO-d6, 300MHz) δ:
4.01, 4.23 (d, 2H, CH2), 6.90 (s, 1H, CH), 7.09–8.19 (m, 8H, Hring),
12.41 (s, 1H, NHbenzimidazole); IR(KBr)υ: 3077, 2927, 1710, 1604, 1534,
1486 cm−1; Anal. Calcd for C16H12N4O3S: C, 56.46; H, 3.55; N, 16.46.
Found: C, 56.28; H, 3.46; N, 16.01%.
4a
4b
4c
4d
4e
4a
4b
4c
4d
4e
2-Chloro
MW
MW
MW
MW
MW
CH
30 min
30 min
30 min
30 min
30 min
12h
400 W
400 W
400 W
400 W
400 W
110 °C
110 °C
110 °C
110 °C
110 °C
82%
79%
85%
82%
81%
54%
51%
60%
56%
58%
4-Fluoro
4-Nitro
4-Methyl
4-Trifluoromethyl
2-Chloro
4-Fluoro
CH
12h
4-Nitro
CH
12h
4-Methyl
CH
12h
4-Trifluoromethyl
CH
12h
MW, microware irradiation; CH, conventional heating.
3-(1H-benzo[d]imidazol-2-yl)-2-p-tolylthiazolidin-4-one (4d):Yield,
82%; m.p. 255–256 °C; 1H NMR (DMSO-d6, 300MHz) δ: 2.31
(t, 3H, CH3), 3.91, 4.14 (d, 2H, CH2), 6.73 (s, 1H, CH), 7.08–7.45 (m,
8H, Hring), 12.25 (s, 1H, NHbenzimidazole); IR(KBr)υ: 3051, 2919, 1703,
1536, 1484 cm−1; Anal. Calcd for C17H15N3OS: C, 66.00; H, 4.89; N,
13.58. Found: C, 66.08; H, 4.56; N, 13.41%.
3-(1H-benzo[d]imidazol-2-yl)-2-(4-(trifluoromethyl)phenyl)thiazol
idin-4-one (4e): (81%): m.p. 247–248 °C; 1H NMR (DMSO-d6,
300MHz) δ: 3.97, 4.22 (d, 2H, CH2), 6.87 (s, 1H, CH), 7.07–7.71 (m,
8H, Hring), 12.44 (s, 1H, NHbenzimidazole); IR(KBr)υ: 3054, 2910, 1709,
1537, 1488, 1226 cm−1; Anal. Calcd for C17H12F3N3OS: C, 56.19; H,
3.33; N, 11.56. found: C, 56.28; H, 3.39; N, 11.51%.
50% NaOH (10 mL) was added. After cooling and filtering, crude
compound 2 was obtained. The pure compound 2 was obtained by
recrystallisation from ethanol.
Preparation of 3; general procedure
A mixture of compound 2 (0.01 mol), substituted benzaldehyde
(0.015 mol) and a small amount of piperidine in toluene was stirred
and irradiated in WF-4000M microwave fast reaction system under
400W for 12 min at 110 °C. After cooling and filtering, crude
compound 3 was obtained. The pure compounds were obtained by
recrystallisation from ethanol.
Preparation of 4; general procedure
The generous financial support of this work came from
the National High Technology Research and Development
(863 Program) of China (No. 2007AA06A402), Key Projects
in the National Science and Technology Pillar Program
(No. 2006BAC02A15), Key Projects in the National Water
pollution control and management Pillar Program (No.
2008ZX07101-003), 2011 Key projects of Natural Science of
Jiangsu Province-owned colleges (NO.11KJA610001).
A mixture of compound 3 (0.005 mol) and toluene (50 mL) was
treated with thioglycollic acid (0.005 mol) dropwise and irradiated
in an experimental MW instrument at 400W for 30 min (max. temp.
110 °C). After completion of the reaction, the remaining toluene
was evaporated under reduced pressure. After cooling, the crude
product precipitated. It was filtered, washed with ethanol, dried, and
recrystallised from ethanol to afford the target compound.
N-(2-chlorobenzylidene)-1H-benzo[d]imidazol-2-amine (3a): Yield,
1
83%; m.p. 222–223 °C; H NMR (DMSO-d6, 400 MHz) δ: 12.80
(s, 1H, NHbenzimidazole), 9.79 (s, 1H, Harom), 7.20-8.28 (m, 8H, Hring);
IR(KBr)υ: 3056 (ArH), 1634 (C=N, ring), 1563 (C=N, imine), 1461
(C–N) cm−1; Anal. Calcd for C14H10ClN3: C, 65.76; H, 3.94; N, 16.43.
Found: C, 65.02; H, 4.04; N, 16.17%.
Received 26 October 2011; accepted 1 November 2011
Paper 1100955 doi: 10.3184/174751911X13203357106346
Published online: 22 November 2011
N-(4-fluorobenzylidene)-1H-benzo[d]imidazol-2-amine (3b): Yield,
1
82%; m.p. 185–186 °C; H NMR (DMSO-d6, 300 MHz) δ: 12.65
References
(s, 1H, NHbenzimidazole), 9.46 (s, 1H, Harom), 7.07–8.17 (m, 7H, Hring);
IR (KBr)υ: 3065 (ArH), 1615 (C=N, ring), 1587 (C=N, imine), 1461
(C–N) cm−1; Anal. Calcd for C14H10FN3: C, 70.28; H, 4.21; N, 17.56.
Found: C, 70.22; H, 4.25; N, 17.51%.
1
W. Nawrocka, B. Sztuba, M.W. Kowalska, H. Liszkiewicz, J. Wietrzyk,
A. Nasulewicz, M. Pełczyńska and A. Opolski, Il Farmaco, 2002, 57, 101.
J. Valdez, R. Cedillo, A. Hernández-Campos, L.Yépez, F. Hernández-Luis,
G. Navarrete-Vázquez, A. Tapia, R. Cortés, M. Hernández and R. Castillo,
Bioorg. Med. Chem. Lett., 2002, 12, 2221.
2
N-(4-nitrobenzylidene)-1H-benzo[d]imidazol-2-amine (3c): Yield,
1
90%; m.p. 285–286 °C; H NMR (DMSO-d6, 400 MHz) δ: 12.85
3
Y.F. Li, G.F. Wang, P.L. He, W.G. Huang, F.H. Zhu, H.Y. Gao, W. Tang,
Y. Luo, C.L. Feng, L.P. Shi, Y.D. Ren, W. Lu and J.P. Zuo, J. Med. Chem.,
2006, 49, 4790.
(s, 1H, NHbenzimidazole), 9.60 (s, 1H, Harom), 7.19–8.42 (m, 8H, Hring);
IR(KBr)υ: 3122 (ArH), 1613 (C=N, ring), 1590 (C=N, imine), 1425
(C–N) cm−1; Anal. Calcd for C14H10N4O2: C, 63.15; H, 3.79; N, 21.04.
Found: C, 63.18; H, 3.25; N, 21.08%.
4
5
6
7
8
A.H. El-masry, H.H. Fahmy and S.H. Ali Abdelwahed, Molecules, 2000, 5,
1429.
S.A. Rogers, R.W. Huigens III and C. Melander, J. Am. Chem. Soc., 2009,
131, 9868.
H. Chen, L. Jiao, Z. Guo, X. Li, C. Ba and J. Zhang, Carbohydr. Res., 2008
343, 3015.
P. Vicini, A. Geronikaki, M. Incerti, F. Zani, J. Deardenc and M. Hewitt,
Bioorg. Med. Chem., 2008, 16, 3714.
G. Navarrete-Vázquez, R. Cedillo, A. Hernández-Camposa, L. Yépezb,
F. Hernández-Luisa, J. Valdeza, R. Moralesb, R. Cortésc, M. Hernándezc
and R. Castilloa, Bioorg. Med. Chem. Lett., 2001, 11, 187.
G. Navarrete-Vázquez, M.M. Rojano-Vilchis, L. Yépez-Mulia, V.
Meléndez, L. Gerena,A. Hernández-Campos, R. Castillo and F. Hernández-
Luis, Eur. J. Med. Chem., 2006, 41, 135.
N-(4-methylbenzylidene)-1H-benzo[d]imidazol-2-amine (3d): Yield,
1
85%; m.p. 238–239 °C; H NMR (DMSO-d6, 300 MHz) δ: 12.65
(s, 1H, NHbenzimidazole), 9.40 (s, 1H, Harom), 7.07–7.97 (m, 8H, Hring), 2.42
(s, 3H, CH3); IR(KBr)υ: 3054 (ArH), 1666 (C=N, ring), 1566 (C=N,
imine), 1440 (C–N) cm−1; Anal. Calcd for C15H13N3: C, 76.57; H, 5.57;
N, 17.86. Found: C, 76.51; H, 5.60; N, 17.82%.
N-(4-(trifluoromethyl)benzylidene)-1H-benzo[d]imidazol-2-amine
(3e):Yield, 79%; m.p. 232–234 °C; 1H NMR (DMSO-d6, 300MHz) δ:
12.80 (s, 1H, NHbenzimidazole), 9.56 (s, 1H, Harom), 7.09–8.29 (m, 8H,
Hring); IR(KBr)υ: 3067 (ArH), 1611 (C=N, ring), 1576 (C=N, imine),
1429 (C–N) cm−1; Anal. Calcd for C15H10F3N3: C, 62.28; H, 3.48; N,
14.53. Found: C, 62.33; H, 3.51; N, 14.60%.
9
10 V.P. Rahman, S. Mukhtar, W.H. Ansari, G. Lemiere, Eur. J. Med. Chem.,
2005, 40, 173.
11 J. Hu, J. Sun, T. Zhou and Y. Xu, J. Chem. Res., 2011, 35, 442
12 J. Hu, J. Wang, T. Zhou and Y. Xu, J. Chem. Res., 35, 525.
3-(1H-benzo[d]imidazol-2-yl)-2-(2-chlorophenyl)thiazolidin-4-one
(4a): Yield, 82%; m.p. 219–220 °C; 1H NMR (DMSO-d6, 300 MHz)